off-label use of glp-1 agonists for obesity in 2016 Emerging Role Obesity: A Comprehensive Review of Randomised Controlled Trials The expanding role of GLP-1
Description
USA 106 , 12851290 (2009)
Complementing these findings, a one-year randomized controlled trial by Villareal and colleagues demonstrated that obese older adults who achieved a 10.1% weight loss through combined diet and exercise experienced significant decreases in hip BMDincluding the trochanter and femoral neckwhile spine and whole-body BMD were preserved
and A.K
Prediction of low bone mineral density in patients with inflammatory bowel diseases
